These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 14231296)

  • 1. [STUDY OF THE MECHANISM OF ACTION OF STUART-PROWER FACTOR (FACTOR X) IN THE FORMATION OF ENDOGENOUS THROMBOPLASTIN].
    ASCARI E; BARBIERI U; GOBBI F
    Minerva Med; 1964 Oct; 55():3210-5. PubMed ID: 14231296
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sharing by the activated forms of precursors and plasmatic components of thromboplastin (PTA, PTC) and by the Stuart-Prower factor in the formation of the coagulo-accelerating principle of the serum].
    Nenci GG; Lechler E
    Haematologica; 1967; 52(4):309-20. PubMed ID: 4976387
    [No Abstract]   [Full Text] [Related]  

  • 3. [THE STUART-PROWER FACTOR: ITS COAGULATION PHYSIOLOGY AND CLINICAL SIGNIFICANCE].
    HIEMEYER V; HOERDER MH
    Klin Wochenschr; 1964 Nov; 42():1103-7. PubMed ID: 14348290
    [No Abstract]   [Full Text] [Related]  

  • 4. Observations on the separate assessment of Prower-Stuart factor activities.
    GARDIKAS C; LYBERATOS C; KALLINIKOS G; KALLINIKOU M
    J Clin Pathol; 1962 Nov; 15(6):501-2. PubMed ID: 13946524
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Coagulation tests from capillary blood. Determination of thromboplastin time, thrombin time, fibrinogen, factor II (prothrombin), factor V (accelerin) and factor X (Stuart-Prower factor) from capillary blood].
    Muntean W
    Z Kinderheilkd; 1975; 118(4):337-46. PubMed ID: 1130122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canine factor X (Stuart-Prower factor) deficiency.
    Dodds WJ
    J Lab Clin Med; 1973 Oct; 82(4):560-6. PubMed ID: 4755433
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of proconvertin and Stuart factor in the inactivation of tissue thromboplastin by serum.
    HERMANSKY F; VITEK J
    Experientia; 1960 Oct; 16():455-6. PubMed ID: 13713641
    [No Abstract]   [Full Text] [Related]  

  • 8. [RESPONSE OF FACTOR X (STUART FACTOR) TO VARIOUS THROMBOPLASTINS].
    BERKARDA B; DERMAN U
    Turk Tip Cemiy Mecm; 1963 Nov; 29():608-11. PubMed ID: 14100583
    [No Abstract]   [Full Text] [Related]  

  • 9. A simple assay method for factor X (Stuart-Prower factor).
    HOUGIE C
    Proc Soc Exp Biol Med; 1962 Mar; 109():754-6. PubMed ID: 14449283
    [No Abstract]   [Full Text] [Related]  

  • 10. Review of the present status of other clotting factors: e) Factor X (Stuart-Prower factor).
    GRAHAM JB; HOUGIE C
    Thromb Diath Haemorrh; 1961; 6(Suppl 1)():416-20. PubMed ID: 13949772
    [No Abstract]   [Full Text] [Related]  

  • 11. THROMBOPLASTIC ENZYMES.
    FERGUSON JH; ENNIS EG; IATRIDIS PG
    Fed Proc; 1964; 23():762-72. PubMed ID: 14195460
    [No Abstract]   [Full Text] [Related]  

  • 12. [Blood coagulation disorder in a 7-year-old child with a partial factor X or Stuart-Prower factor deficiency].
    Violante N; Ciavarella N
    Haematologica; 1972; 58(9):587-93. PubMed ID: 4206233
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors influencing the consumption of factor X (Stuart-Prower factor) during intrinsic coagulation.
    Niemetz J
    Thromb Diath Haemorrh; 1967 Dec; 18(3-4):332-41. PubMed ID: 4952976
    [No Abstract]   [Full Text] [Related]  

  • 14. [THEORIES CONCERNING FACTOR X (STUART-PROWER) IN LIVER DISEASES AND IN TREATMENT WITH INDIRECT ANTICOAGULANTS].
    PARREIRA F; ANTUNES ML; SEQUEIRA J; NUNES V
    J Soc Cienc Med Lisb; 1964 Mar; 128():179-92. PubMed ID: 14151145
    [No Abstract]   [Full Text] [Related]  

  • 15. [Research on the mechanism of action of proaccelerin (factor V, labile factor). I. Proaccelerin in the formation of endogenous thromboplastin].
    GOBBI F; ASCARI E; BARBIERI U
    Prog Med (Napoli); 1961 Sep; 17():580-7. PubMed ID: 13899355
    [No Abstract]   [Full Text] [Related]  

  • 16. ACTIVATION OF FACTOR X.
    LECHNER K; DEUTSCH E
    Thromb Diath Haemorrh; 1965 Jun; 13():314-29. PubMed ID: 14347857
    [No Abstract]   [Full Text] [Related]  

  • 17. [Thromboplastin formation in the serum of full-term and premature newborn infants in relation to Stuart factor activity].
    VECCHIO F; SCHETTINI F; DI FRANCESCO L
    Boll Soc Ital Biol Sper; 1959 Aug; 35():964-8. PubMed ID: 13841525
    [No Abstract]   [Full Text] [Related]  

  • 18. TISSUE EXTRACTS AND THEIR SENSITIVITY TO FACTOR VII AND FACTOR X.
    DENSON KW
    Thromb Diath Haemorrh; 1964 Apr; 11():146-54. PubMed ID: 14171582
    [No Abstract]   [Full Text] [Related]  

  • 19. Stuart-Prower factor deficiency and oral surgery.
    Quast UR; Sibinga CT; Wijnja L
    Br J Oral Surg; 1971 Nov; 9(21):146-50. PubMed ID: 5316888
    [No Abstract]   [Full Text] [Related]  

  • 20. THE ACTIVATION OF FACTOR X BY EXTRACTS OF RABBIT BRAIN.
    NEMERSON Y; SPAET TH
    Blood; 1964 May; 23():657-68. PubMed ID: 14142504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.